About this episode

The episode discusses the implications of Elon Musk's trial against OpenAI, the revised partnership between OpenAI and Microsoft, and various developments in the AI industry.

Elon Musk's federal trial against OpenAI opened this week, and he admitted under oath that xAI distills OpenAI's models. That's just where Episode 212 starts. Paul and Mike cover the full story: the Musk-OpenAI trial and its implications for every company built on ChatGPT, the abrupt rewrite of the Microsoft-OpenAI partnership and the removal of the AGI clause, blockbuster Big Tech earnings (Google Cloud up 63%, Azure AI at $37B run rate), an AI agent that wiped a startup's entire production database in nine seconds, Anthropic eyeing a $900B valuation, a real and growing populist AI backlash, and a powerful segment on former Senator Ben Sasse's terminal cancer diagnosis and what his parting words on AI and Congress mean right now. Show Notes: Access the show notes and show links here AI-Pulse Survey: Fill out this week’s AI-Pulse Survey here. Timestamps: 00:00:00 — Intro 00:04:45 — Elon Musk vs. OpenAI Trial Begins 00:14:49 — OpenAI and Microsoft Revise Their Partnership 00:30:33 — Big Tech Earnings 00:39:39 — Anthropic Eyes $900B Valuation 00:43:53 — Trump's Anthropic Reversal and Mythos Fight 00:52:48 — Agents Gone Wrong 00:56:47 — Myths We Tell Ourselves About AI and Jobs…

People in this episode

Hosts: Paul Roetzer, Mike Kaput

Topics covered

• Musk v. OpenAI trial
• OpenAI-Microsoft partnership
• Big Tech earnings
• Anthropic valuation
• AI backlash
• AI and Congress

Sponsors

AI Academy

Mentioned in this episode

Organizations: OpenAI, xAI, Microsoft, Google Cloud, Azure AI, Anthropic

Explore listener stats, chart rankings, contacts and more on the The Artificial Intelligence Show podcast page.